Screener
Aurinia Pharmaceuticals AUPH Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Purchases of property, equipment and intangible assets | (39) | (115) |
| Cash flows from investing activities | 63,368 | 17,759 |
| Cash flows from financing activities: | ||
| Purchase of common shares under Share Repurchase Plan | (74,880) | (89,485) |
| Payments of principal portion of Monoplant finance lease liability | (7,058) | (6,201) |
| Proceeds from issuance of common shares for equity awards | 59,154 | 10,590 |
| Proceeds from issuance of common shares under ESPP | 363 | 401 |
| Tax withholding payments related to net settlements of equity awards | (26,454) | (9,036) |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's share buybacks?
- Aurinia Pharmaceuticals (AUPH) reported share buybacks of $38.72M in Q2 2026.
- How has Aurinia Pharmaceuticals's share buybacks changed year-over-year?
- Aurinia Pharmaceuticals's share buybacks decreased by 9.0% year-over-year, from $42.56M to $38.72M.
- What does share buybacks mean?
- Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.
Ask your AI about Aurinia Pharmaceuticals's share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude